Relationship Between Genitourinary and Respiratory Symptoms in Postmanopause
Investigation of the Relationship Between Genitourinary System Symptoms, Respiratory Functions, and Respiratory Muscle Strength in the Postmenopausal Period
1 other identifier
observational
28
1 country
1
Brief Summary
The aim of this study is to evaluate the relationship between genitourinary system symptoms and respiratory function and respiratory muscle strength in postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 8, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedJune 16, 2026
June 1, 2026
Same day
June 8, 2026
June 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Bristol Female Lower Urinary Tract Symptoms Index (BUTSI)
The BUTSI, for which a Turkish validity and reliability study has been conducted, consists of five sections evaluating storage symptoms; voiding symptoms ; urinary incontinence ; sexual function ; and quality of life The maximum total score is 60.A higher total score on the scale indicates a more negative impact on sexual life and quality of life, and more severe lower urinary tract symptoms.
at baseline
Postmenopausal Sexuality Questionnaire (PSQ)
The MSCA, for which Turkish validity and reliability studies have been conducted, consists of a total of 36 items and nine sub-dimensions.The maximum total score is 100. A score of zero indicates the worst sexual function, while a score of 100 indicates the best sexual function (0-100).
at baseline
Respiratory function
The evaluation was performed using a Cosmed Pony FX brand spirometer, in accordance with the criteria.A forced vital capacity maneuver test was administered to assess the respiratory function of the participants. During the forced vital capacity maneuver, the participant was asked to take a deep breath and, when they could no longer breathe, to forcefully, quickly, and for an extended period exhale all the air from their lungs, then take another deep breath. As a result of this test, forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio, and peak airflow rate (PEF) values were obtained and recorded.
at baseline.
respiratory muscle strength
The evaluation was performed using a Cosmed Pony FX brand spirometer. Maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) tests were performed to assess the strength of the respiratory muscles. For the MIP test, the participant was asked to first completely exhale the air from their lungs, followed by a deep, rapid, and forceful full breath; for the MEP test, the participant was asked to first completely fill their lungs with air, followed by a rapid and forceful full exhale. MIP and MEP values were used as percentages of the expected values for gender and age, and Black and Hyatt equations were used when interpreting the values.
at baseline.
Study Arms (1)
Women in Postmenopausal Period
All women who are postmenopausal and meet the participation criteria.
Eligibility Criteria
All women who are postmenopausal and meet the participation criteria.
You may qualify if:
- being between 50-64 years of age,
- having passed menopause no more than eight years ago,
- having experienced at least one pregnancy,
- being literate;
You may not qualify if:
- having received/currently receiving hormone replacement therapy,
- having any respiratory system disorder;
- having a serious chronic and/or metabolic disorder that may affect the outcome of the study;
- having cooperation problems.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Halic Universitylead
Study Sites (1)
Halic University
Istanbul, Turkey (Türkiye)
Related Publications (2)
Kurne HG, Akbayrak T. The validity and reliability of the Turkish version of the Postmenopause Sexuality Questionnaire. Int J Gynaecol Obstet. 2024 Apr;165(1):188-193. doi: 10.1002/ijgo.15293. Epub 2023 Dec 12.
PMID: 38084782RESULTSarmento ACA, Costa APF, Vieira-Baptista P, Giraldo PC, Eleuterio J Jr, Goncalves AK. Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation and Diagnostic. Front Reprod Health. 2021 Nov 15;3:779398. doi: 10.3389/frph.2021.779398. eCollection 2021.
PMID: 36304000RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Duygu ŞAHİN, PT, PhD.
Halic University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2026
First Posted
June 16, 2026
Study Start
May 1, 2025
Primary Completion
May 1, 2025
Study Completion
March 1, 2026
Last Updated
June 16, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share